Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19)

The recent release of the main protein structures belonging to SARS CoV-2, responsible for the coronavirus disease-19 (COVID-19), strongly pushed for identifying valuable drug treatments. With this aim, we show a repurposing study on FDA-approved drugs applying a new computational protocol and intro...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vita, Simona, Chini, Maria Giovanna, Lauro, Gianluigi, Bifulco, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057693/
https://www.ncbi.nlm.nih.gov/pubmed/35519188
http://dx.doi.org/10.1039/d0ra09010g

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057693/
https://www.ncbi.nlm.nih.gov/pubmed/35519188
http://dx.doi.org/10.1039/d0ra09010g

Ejemplares similares